Global Chronic Idiopathic Constipation Drugs Market Growth 2025-2031

Product Code: 1679941

Industry: Pharma & Healthcare

Published: Jun 25,2025

Pages: 133

Delivery Time: 2-3 business days

Global Chronic Idiopathic Constipation Drugs Market Growth 2025-2031

Product Code: 1679941

Industry: Pharma & Healthcare

Published: Jun 25,2025

Pages: 133

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Chronic Idiopathic Constipation Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Chronic Idiopathic Constipation Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Chronic Idiopathic Constipation Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Chronic Idiopathic Constipation Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Chronic Idiopathic Constipation Drugs players cover Pfizer, Glaxosmithkline, Roche Holding AG, Sanofi, Bayer AG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Chronic Idiopathic Constipation Drugs Industry Forecast” looks at past sales and reviews total world Chronic Idiopathic Constipation Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Chronic Idiopathic Constipation Drugs sales for 2025 through 2031. With Chronic Idiopathic Constipation Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Idiopathic Constipation Drugs industry.

This Insight Report provides a comprehensive analysis of the global Chronic Idiopathic Constipation Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Idiopathic Constipation Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Idiopathic Constipation Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Idiopathic Constipation Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Idiopathic Constipation Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Idiopathic Constipation Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Linaclotide
    Lubiprostone
    Others

Segmentation by Application:
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Pfizer
    Glaxosmithkline
    Roche Holding AG
    Sanofi
    Bayer AG
    Merck
    Eli Lilly
    Allergens
    Chugai Pharmaceutical
    Ferring International Center S.A
    Synergy Pharmaceuticals
    Salix Pharmaceuticals Ltd
    Sucampo Pharmaceuticals Inc
    Ironwood Pharmaceuticals Inc
    Bausch Health
    Daiichi Sankyo
    Cosmo Pharmaceuticals SA
    Progenics Pharmaceuticals Inc
    Theravance Biopharma Inc

Key Questions Addressed in this Report
What is the 10-year outlook for the global Chronic Idiopathic Constipation Drugs market?
What factors are driving Chronic Idiopathic Constipation Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Idiopathic Constipation Drugs market opportunities vary by end market size?
How does Chronic Idiopathic Constipation Drugs break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Chronic Idiopathic Constipation Drugs Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Chronic Idiopathic Constipation Drugs by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Chronic Idiopathic Constipation Drugs by Country/Region, 2020, 2024 & 2031
    2.2 Chronic Idiopathic Constipation Drugs Segment by Type
        2.2.1 Linaclotide
        2.2.2 Lubiprostone
        2.2.3 Others
    2.3 Chronic Idiopathic Constipation Drugs Sales by Type
        2.3.1 Global Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2020-2025)
        2.3.2 Global Chronic Idiopathic Constipation Drugs Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Chronic Idiopathic Constipation Drugs Sale Price by Type (2020-2025)
    2.4 Chronic Idiopathic Constipation Drugs Segment by Application
        2.4.1 Hospital Pharmacies
        2.4.2 Retail Pharmacies
        2.4.3 Online Pharmacies
    2.5 Chronic Idiopathic Constipation Drugs Sales by Application
        2.5.1 Global Chronic Idiopathic Constipation Drugs Sale Market Share by Application (2020-2025)
        2.5.2 Global Chronic Idiopathic Constipation Drugs Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Chronic Idiopathic Constipation Drugs Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Chronic Idiopathic Constipation Drugs Breakdown Data by Company
        3.1.1 Global Chronic Idiopathic Constipation Drugs Annual Sales by Company (2020-2025)
        3.1.2 Global Chronic Idiopathic Constipation Drugs Sales Market Share by Company (2020-2025)
    3.2 Global Chronic Idiopathic Constipation Drugs Annual Revenue by Company (2020-2025)
        3.2.1 Global Chronic Idiopathic Constipation Drugs Revenue by Company (2020-2025)
        3.2.2 Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Company (2020-2025)
    3.3 Global Chronic Idiopathic Constipation Drugs Sale Price by Company
    3.4 Key Manufacturers Chronic Idiopathic Constipation Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Chronic Idiopathic Constipation Drugs Product Location Distribution
        3.4.2 Players Chronic Idiopathic Constipation Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Chronic Idiopathic Constipation Drugs by Geographic Region
    4.1 World Historic Chronic Idiopathic Constipation Drugs Market Size by Geographic Region (2020-2025)
        4.1.1 Global Chronic Idiopathic Constipation Drugs Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Chronic Idiopathic Constipation Drugs Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Chronic Idiopathic Constipation Drugs Market Size by Country/Region (2020-2025)
        4.2.1 Global Chronic Idiopathic Constipation Drugs Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Chronic Idiopathic Constipation Drugs Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Chronic Idiopathic Constipation Drugs Sales Growth
    4.4 APAC Chronic Idiopathic Constipation Drugs Sales Growth
    4.5 Europe Chronic Idiopathic Constipation Drugs Sales Growth
    4.6 Middle East & Africa Chronic Idiopathic Constipation Drugs Sales Growth

5 Americas
    5.1 Americas Chronic Idiopathic Constipation Drugs Sales by Country
        5.1.1 Americas Chronic Idiopathic Constipation Drugs Sales by Country (2020-2025)
        5.1.2 Americas Chronic Idiopathic Constipation Drugs Revenue by Country (2020-2025)
    5.2 Americas Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025)
    5.3 Americas Chronic Idiopathic Constipation Drugs Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Chronic Idiopathic Constipation Drugs Sales by Region
        6.1.1 APAC Chronic Idiopathic Constipation Drugs Sales by Region (2020-2025)
        6.1.2 APAC Chronic Idiopathic Constipation Drugs Revenue by Region (2020-2025)
    6.2 APAC Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025)
    6.3 APAC Chronic Idiopathic Constipation Drugs Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Chronic Idiopathic Constipation Drugs by Country
        7.1.1 Europe Chronic Idiopathic Constipation Drugs Sales by Country (2020-2025)
        7.1.2 Europe Chronic Idiopathic Constipation Drugs Revenue by Country (2020-2025)
    7.2 Europe Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025)
    7.3 Europe Chronic Idiopathic Constipation Drugs Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Chronic Idiopathic Constipation Drugs by Country
        8.1.1 Middle East & Africa Chronic Idiopathic Constipation Drugs Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue by Country (2020-2025)
    8.2 Middle East & Africa Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025)
    8.3 Middle East & Africa Chronic Idiopathic Constipation Drugs Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Chronic Idiopathic Constipation Drugs
    10.3 Manufacturing Process Analysis of Chronic Idiopathic Constipation Drugs
    10.4 Industry Chain Structure of Chronic Idiopathic Constipation Drugs

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Chronic Idiopathic Constipation Drugs Distributors
    11.3 Chronic Idiopathic Constipation Drugs Customer

12 World Forecast Review for Chronic Idiopathic Constipation Drugs by Geographic Region
    12.1 Global Chronic Idiopathic Constipation Drugs Market Size Forecast by Region
        12.1.1 Global Chronic Idiopathic Constipation Drugs Forecast by Region (2026-2031)
        12.1.2 Global Chronic Idiopathic Constipation Drugs Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Chronic Idiopathic Constipation Drugs Forecast by Type (2026-2031)
    12.7 Global Chronic Idiopathic Constipation Drugs Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Pfizer
        13.1.1 Pfizer Company Information
        13.1.2 Pfizer Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.1.3 Pfizer Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Pfizer Main Business Overview
        13.1.5 Pfizer Latest Developments
    13.2 Glaxosmithkline
        13.2.1 Glaxosmithkline Company Information
        13.2.2 Glaxosmithkline Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.2.3 Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Glaxosmithkline Main Business Overview
        13.2.5 Glaxosmithkline Latest Developments
    13.3 Roche Holding AG
        13.3.1 Roche Holding AG Company Information
        13.3.2 Roche Holding AG Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.3.3 Roche Holding AG Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Roche Holding AG Main Business Overview
        13.3.5 Roche Holding AG Latest Developments
    13.4 Sanofi
        13.4.1 Sanofi Company Information
        13.4.2 Sanofi Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.4.3 Sanofi Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Sanofi Main Business Overview
        13.4.5 Sanofi Latest Developments
    13.5 Bayer AG
        13.5.1 Bayer AG Company Information
        13.5.2 Bayer AG Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.5.3 Bayer AG Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Bayer AG Main Business Overview
        13.5.5 Bayer AG Latest Developments
    13.6 Merck
        13.6.1 Merck Company Information
        13.6.2 Merck Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.6.3 Merck Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Merck Main Business Overview
        13.6.5 Merck Latest Developments
    13.7 Eli Lilly
        13.7.1 Eli Lilly Company Information
        13.7.2 Eli Lilly Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.7.3 Eli Lilly Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Eli Lilly Main Business Overview
        13.7.5 Eli Lilly Latest Developments
    13.8 Allergens
        13.8.1 Allergens Company Information
        13.8.2 Allergens Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.8.3 Allergens Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Allergens Main Business Overview
        13.8.5 Allergens Latest Developments
    13.9 Chugai Pharmaceutical
        13.9.1 Chugai Pharmaceutical Company Information
        13.9.2 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.9.3 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 Chugai Pharmaceutical Main Business Overview
        13.9.5 Chugai Pharmaceutical Latest Developments
    13.10 Ferring International Center S.A
        13.10.1 Ferring International Center S.A Company Information
        13.10.2 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.10.3 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 Ferring International Center S.A Main Business Overview
        13.10.5 Ferring International Center S.A Latest Developments
    13.11 Synergy Pharmaceuticals
        13.11.1 Synergy Pharmaceuticals Company Information
        13.11.2 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.11.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 Synergy Pharmaceuticals Main Business Overview
        13.11.5 Synergy Pharmaceuticals Latest Developments
    13.12 Salix Pharmaceuticals Ltd
        13.12.1 Salix Pharmaceuticals Ltd Company Information
        13.12.2 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.12.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 Salix Pharmaceuticals Ltd Main Business Overview
        13.12.5 Salix Pharmaceuticals Ltd Latest Developments
    13.13 Sucampo Pharmaceuticals Inc
        13.13.1 Sucampo Pharmaceuticals Inc Company Information
        13.13.2 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.13.3 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.13.4 Sucampo Pharmaceuticals Inc Main Business Overview
        13.13.5 Sucampo Pharmaceuticals Inc Latest Developments
    13.14 Ironwood Pharmaceuticals Inc
        13.14.1 Ironwood Pharmaceuticals Inc Company Information
        13.14.2 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.14.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.14.4 Ironwood Pharmaceuticals Inc Main Business Overview
        13.14.5 Ironwood Pharmaceuticals Inc Latest Developments
    13.15 Bausch Health
        13.15.1 Bausch Health Company Information
        13.15.2 Bausch Health Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.15.3 Bausch Health Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.15.4 Bausch Health Main Business Overview
        13.15.5 Bausch Health Latest Developments
    13.16 Daiichi Sankyo
        13.16.1 Daiichi Sankyo Company Information
        13.16.2 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.16.3 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.16.4 Daiichi Sankyo Main Business Overview
        13.16.5 Daiichi Sankyo Latest Developments
    13.17 Cosmo Pharmaceuticals SA
        13.17.1 Cosmo Pharmaceuticals SA Company Information
        13.17.2 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.17.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.17.4 Cosmo Pharmaceuticals SA Main Business Overview
        13.17.5 Cosmo Pharmaceuticals SA Latest Developments
    13.18 Progenics Pharmaceuticals Inc
        13.18.1 Progenics Pharmaceuticals Inc Company Information
        13.18.2 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.18.3 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.18.4 Progenics Pharmaceuticals Inc Main Business Overview
        13.18.5 Progenics Pharmaceuticals Inc Latest Developments
    13.19 Theravance Biopharma Inc
        13.19.1 Theravance Biopharma Inc Company Information
        13.19.2 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
        13.19.3 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
        13.19.4 Theravance Biopharma Inc Main Business Overview
        13.19.5 Theravance Biopharma Inc Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Chronic Idiopathic Constipation Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Chronic Idiopathic Constipation Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Linaclotide
 Table 4. Major Players of Lubiprostone
 Table 5. Major Players of Others
 Table 6. Global Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
 Table 7. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2020-2025)
 Table 8. Global Chronic Idiopathic Constipation Drugs Revenue by Type (2020-2025) & ($ million)
 Table 9. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2020-2025)
 Table 10. Global Chronic Idiopathic Constipation Drugs Sale Price by Type (2020-2025) & (USD/Pcs)
 Table 11. Global Chronic Idiopathic Constipation Drugs Sale by Application (2020-2025) & (K Pcs)
 Table 12. Global Chronic Idiopathic Constipation Drugs Sale Market Share by Application (2020-2025)
 Table 13. Global Chronic Idiopathic Constipation Drugs Revenue by Application (2020-2025) & ($ million)
 Table 14. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application (2020-2025)
 Table 15. Global Chronic Idiopathic Constipation Drugs Sale Price by Application (2020-2025) & (USD/Pcs)
 Table 16. Global Chronic Idiopathic Constipation Drugs Sales by Company (2020-2025) & (K Pcs)
 Table 17. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Company (2020-2025)
 Table 18. Global Chronic Idiopathic Constipation Drugs Revenue by Company (2020-2025) & ($ millions)
 Table 19. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Company (2020-2025)
 Table 20. Global Chronic Idiopathic Constipation Drugs Sale Price by Company (2020-2025) & (USD/Pcs)
 Table 21. Key Manufacturers Chronic Idiopathic Constipation Drugs Producing Area Distribution and Sales Area
 Table 22. Players Chronic Idiopathic Constipation Drugs Products Offered
 Table 23. Chronic Idiopathic Constipation Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 24. New Products and Potential Entrants
 Table 25. Market M&A Activity & Strategy
 Table 26. Global Chronic Idiopathic Constipation Drugs Sales by Geographic Region (2020-2025) & (K Pcs)
 Table 27. Global Chronic Idiopathic Constipation Drugs Sales Market Share Geographic Region (2020-2025)
 Table 28. Global Chronic Idiopathic Constipation Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 29. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Geographic Region (2020-2025)
 Table 30. Global Chronic Idiopathic Constipation Drugs Sales by Country/Region (2020-2025) & (K Pcs)
 Table 31. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Country/Region (2020-2025)
 Table 32. Global Chronic Idiopathic Constipation Drugs Revenue by Country/Region (2020-2025) & ($ millions)
 Table 33. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Country/Region (2020-2025)
 Table 34. Americas Chronic Idiopathic Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 35. Americas Chronic Idiopathic Constipation Drugs Sales Market Share by Country (2020-2025)
 Table 36. Americas Chronic Idiopathic Constipation Drugs Revenue by Country (2020-2025) & ($ millions)
 Table 37. Americas Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
 Table 38. Americas Chronic Idiopathic Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
 Table 39. APAC Chronic Idiopathic Constipation Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 40. APAC Chronic Idiopathic Constipation Drugs Sales Market Share by Region (2020-2025)
 Table 41. APAC Chronic Idiopathic Constipation Drugs Revenue by Region (2020-2025) & ($ millions)
 Table 42. APAC Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
 Table 43. APAC Chronic Idiopathic Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
 Table 44. Europe Chronic Idiopathic Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 45. Europe Chronic Idiopathic Constipation Drugs Revenue by Country (2020-2025) & ($ millions)
 Table 46. Europe Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
 Table 47. Europe Chronic Idiopathic Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
 Table 48. Middle East & Africa Chronic Idiopathic Constipation Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 49. Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue Market Share by Country (2020-2025)
 Table 50. Middle East & Africa Chronic Idiopathic Constipation Drugs Sales by Type (2020-2025) & (K Pcs)
 Table 51. Middle East & Africa Chronic Idiopathic Constipation Drugs Sales by Application (2020-2025) & (K Pcs)
 Table 52. Key Market Drivers & Growth Opportunities of Chronic Idiopathic Constipation Drugs
 Table 53. Key Market Challenges & Risks of Chronic Idiopathic Constipation Drugs
 Table 54. Key Industry Trends of Chronic Idiopathic Constipation Drugs
 Table 55. Chronic Idiopathic Constipation Drugs Raw Material
 Table 56. Key Suppliers of Raw Materials
 Table 57. Chronic Idiopathic Constipation Drugs Distributors List
 Table 58. Chronic Idiopathic Constipation Drugs Customer List
 Table 59. Global Chronic Idiopathic Constipation Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
 Table 60. Global Chronic Idiopathic Constipation Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 61. Americas Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
 Table 62. Americas Chronic Idiopathic Constipation Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 63. APAC Chronic Idiopathic Constipation Drugs Sales Forecast by Region (2026-2031) & (K Pcs)
 Table 64. APAC Chronic Idiopathic Constipation Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 65. Europe Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
 Table 66. Europe Chronic Idiopathic Constipation Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 67. Middle East & Africa Chronic Idiopathic Constipation Drugs Sales Forecast by Country (2026-2031) & (K Pcs)
 Table 68. Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 69. Global Chronic Idiopathic Constipation Drugs Sales Forecast by Type (2026-2031) & (K Pcs)
 Table 70. Global Chronic Idiopathic Constipation Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 71. Global Chronic Idiopathic Constipation Drugs Sales Forecast by Application (2026-2031) & (K Pcs)
 Table 72. Global Chronic Idiopathic Constipation Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 73. Pfizer Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 74. Pfizer Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 75. Pfizer Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 76. Pfizer Main Business
 Table 77. Pfizer Latest Developments
 Table 78. Glaxosmithkline Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 79. Glaxosmithkline Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 80. Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 81. Glaxosmithkline Main Business
 Table 82. Glaxosmithkline Latest Developments
 Table 83. Roche Holding AG Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 84. Roche Holding AG Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 85. Roche Holding AG Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 86. Roche Holding AG Main Business
 Table 87. Roche Holding AG Latest Developments
 Table 88. Sanofi Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 89. Sanofi Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 90. Sanofi Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 91. Sanofi Main Business
 Table 92. Sanofi Latest Developments
 Table 93. Bayer AG Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 94. Bayer AG Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 95. Bayer AG Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 96. Bayer AG Main Business
 Table 97. Bayer AG Latest Developments
 Table 98. Merck Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 99. Merck Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 100. Merck Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 101. Merck Main Business
 Table 102. Merck Latest Developments
 Table 103. Eli Lilly Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 104. Eli Lilly Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 105. Eli Lilly Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 106. Eli Lilly Main Business
 Table 107. Eli Lilly Latest Developments
 Table 108. Allergens Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 109. Allergens Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 110. Allergens Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 111. Allergens Main Business
 Table 112. Allergens Latest Developments
 Table 113. Chugai Pharmaceutical Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 114. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 115. Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 116. Chugai Pharmaceutical Main Business
 Table 117. Chugai Pharmaceutical Latest Developments
 Table 118. Ferring International Center S.A Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 119. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 120. Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 121. Ferring International Center S.A Main Business
 Table 122. Ferring International Center S.A Latest Developments
 Table 123. Synergy Pharmaceuticals Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 124. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 125. Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 126. Synergy Pharmaceuticals Main Business
 Table 127. Synergy Pharmaceuticals Latest Developments
 Table 128. Salix Pharmaceuticals Ltd Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 129. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 130. Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 131. Salix Pharmaceuticals Ltd Main Business
 Table 132. Salix Pharmaceuticals Ltd Latest Developments
 Table 133. Sucampo Pharmaceuticals Inc Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 134. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 135. Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 136. Sucampo Pharmaceuticals Inc Main Business
 Table 137. Sucampo Pharmaceuticals Inc Latest Developments
 Table 138. Ironwood Pharmaceuticals Inc Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 139. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 140. Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 141. Ironwood Pharmaceuticals Inc Main Business
 Table 142. Ironwood Pharmaceuticals Inc Latest Developments
 Table 143. Bausch Health Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 144. Bausch Health Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 145. Bausch Health Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 146. Bausch Health Main Business
 Table 147. Bausch Health Latest Developments
 Table 148. Daiichi Sankyo Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 149. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 150. Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 151. Daiichi Sankyo Main Business
 Table 152. Daiichi Sankyo Latest Developments
 Table 153. Cosmo Pharmaceuticals SA Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 154. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 155. Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 156. Cosmo Pharmaceuticals SA Main Business
 Table 157. Cosmo Pharmaceuticals SA Latest Developments
 Table 158. Progenics Pharmaceuticals Inc Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 159. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 160. Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 161. Progenics Pharmaceuticals Inc Main Business
 Table 162. Progenics Pharmaceuticals Inc Latest Developments
 Table 163. Theravance Biopharma Inc Basic Information, Chronic Idiopathic Constipation Drugs Manufacturing Base, Sales Area and Its Competitors
 Table 164. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Product Portfolios and Specifications
 Table 165. Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 166. Theravance Biopharma Inc Main Business
 Table 167. Theravance Biopharma Inc Latest Developments


List of Figures
 Figure 1. Picture of Chronic Idiopathic Constipation Drugs
 Figure 2. Chronic Idiopathic Constipation Drugs Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Chronic Idiopathic Constipation Drugs Sales Growth Rate 2020-2031 (K Pcs)
 Figure 7. Global Chronic Idiopathic Constipation Drugs Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Chronic Idiopathic Constipation Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Chronic Idiopathic Constipation Drugs Sales Market Share by Country/Region (2024)
 Figure 10. Chronic Idiopathic Constipation Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Linaclotide
 Figure 12. Product Picture of Lubiprostone
 Figure 13. Product Picture of Others
 Figure 14. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Type in 2025
 Figure 15. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Type (2020-2025)
 Figure 16. Chronic Idiopathic Constipation Drugs Consumed in Hospital Pharmacies
 Figure 17. Global Chronic Idiopathic Constipation Drugs Market: Hospital Pharmacies (2020-2025) & (K Pcs)
 Figure 18. Chronic Idiopathic Constipation Drugs Consumed in Retail Pharmacies
 Figure 19. Global Chronic Idiopathic Constipation Drugs Market: Retail Pharmacies (2020-2025) & (K Pcs)
 Figure 20. Chronic Idiopathic Constipation Drugs Consumed in Online Pharmacies
 Figure 21. Global Chronic Idiopathic Constipation Drugs Market: Online Pharmacies (2020-2025) & (K Pcs)
 Figure 22. Global Chronic Idiopathic Constipation Drugs Sale Market Share by Application (2024)
 Figure 23. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Application in 2025
 Figure 24. Chronic Idiopathic Constipation Drugs Sales by Company in 2025 (K Pcs)
 Figure 25. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Company in 2025
 Figure 26. Chronic Idiopathic Constipation Drugs Revenue by Company in 2025 ($ millions)
 Figure 27. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Company in 2025
 Figure 28. Global Chronic Idiopathic Constipation Drugs Sales Market Share by Geographic Region (2020-2025)
 Figure 29. Global Chronic Idiopathic Constipation Drugs Revenue Market Share by Geographic Region in 2025
 Figure 30. Americas Chronic Idiopathic Constipation Drugs Sales 2020-2025 (K Pcs)
 Figure 31. Americas Chronic Idiopathic Constipation Drugs Revenue 2020-2025 ($ millions)
 Figure 32. APAC Chronic Idiopathic Constipation Drugs Sales 2020-2025 (K Pcs)
 Figure 33. APAC Chronic Idiopathic Constipation Drugs Revenue 2020-2025 ($ millions)
 Figure 34. Europe Chronic Idiopathic Constipation Drugs Sales 2020-2025 (K Pcs)
 Figure 35. Europe Chronic Idiopathic Constipation Drugs Revenue 2020-2025 ($ millions)
 Figure 36. Middle East & Africa Chronic Idiopathic Constipation Drugs Sales 2020-2025 (K Pcs)
 Figure 37. Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue 2020-2025 ($ millions)
 Figure 38. Americas Chronic Idiopathic Constipation Drugs Sales Market Share by Country in 2025
 Figure 39. Americas Chronic Idiopathic Constipation Drugs Revenue Market Share by Country (2020-2025)
 Figure 40. Americas Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2020-2025)
 Figure 41. Americas Chronic Idiopathic Constipation Drugs Sales Market Share by Application (2020-2025)
 Figure 42. United States Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 43. Canada Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 44. Mexico Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 45. Brazil Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 46. APAC Chronic Idiopathic Constipation Drugs Sales Market Share by Region in 2025
 Figure 47. APAC Chronic Idiopathic Constipation Drugs Revenue Market Share by Region (2020-2025)
 Figure 48. APAC Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2020-2025)
 Figure 49. APAC Chronic Idiopathic Constipation Drugs Sales Market Share by Application (2020-2025)
 Figure 50. China Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 51. Japan Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 52. South Korea Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 53. Southeast Asia Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 54. India Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 55. Australia Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 56. China Taiwan Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 57. Europe Chronic Idiopathic Constipation Drugs Sales Market Share by Country in 2025
 Figure 58. Europe Chronic Idiopathic Constipation Drugs Revenue Market Share by Country (2020-2025)
 Figure 59. Europe Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2020-2025)
 Figure 60. Europe Chronic Idiopathic Constipation Drugs Sales Market Share by Application (2020-2025)
 Figure 61. Germany Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 62. France Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 63. UK Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 64. Italy Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 65. Russia Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 66. Middle East & Africa Chronic Idiopathic Constipation Drugs Sales Market Share by Country (2020-2025)
 Figure 67. Middle East & Africa Chronic Idiopathic Constipation Drugs Sales Market Share by Type (2020-2025)
 Figure 68. Middle East & Africa Chronic Idiopathic Constipation Drugs Sales Market Share by Application (2020-2025)
 Figure 69. Egypt Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 70. South Africa Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 71. Israel Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 72. Turkey Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 73. GCC Countries Chronic Idiopathic Constipation Drugs Revenue Growth 2020-2025 ($ millions)
 Figure 74. Manufacturing Cost Structure Analysis of Chronic Idiopathic Constipation Drugs in 2025
 Figure 75. Manufacturing Process Analysis of Chronic Idiopathic Constipation Drugs
 Figure 76. Industry Chain Structure of Chronic Idiopathic Constipation Drugs
 Figure 77. Channels of Distribution
 Figure 78. Global Chronic Idiopathic Constipation Drugs Sales Market Forecast by Region (2026-2031)
 Figure 79. Global Chronic Idiopathic Constipation Drugs Revenue Market Share Forecast by Region (2026-2031)
 Figure 80. Global Chronic Idiopathic Constipation Drugs Sales Market Share Forecast by Type (2026-2031)
 Figure 81. Global Chronic Idiopathic Constipation Drugs Revenue Market Share Forecast by Type (2026-2031)
 Figure 82. Global Chronic Idiopathic Constipation Drugs Sales Market Share Forecast by Application (2026-2031)
 Figure 83. Global Chronic Idiopathic Constipation Drugs Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Pfizer

Glaxosmithkline

Roche Holding AG

Sanofi

Bayer AG

Merck

Eli Lilly

Allergens

Chugai Pharmaceutical

Ferring International Center S.A

Synergy Pharmaceuticals

Salix Pharmaceuticals Ltd

Sucampo Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc

Bausch Health

Daiichi Sankyo

Cosmo Pharmaceuticals SA

Progenics Pharmaceuticals Inc

Theravance Biopharma Inc

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff